Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ulthera, Inc
The primary objective of this clinical trial is to demonstrate the effectiveness of the Ulthera® System for non-invasive treatment to reduce wrinkles around the eyes.
Age
30–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male or female, aged 30 to 65 years.
Subject in good health.
Mild to moderate rhytids in the periorbital region.
Willingness and ability to comply with protocol requirements and return for follow-up visits.
Not pregnant.
Provide written informed consent and HIPAA authorization.
You may not be if
Presence of an active systemic or local skin disease that may affect wound healing.
Severe solar elastosis.
Excessive subcutaneous fat in the face.
Deep wrinkles, numerous lines, with or without redundant skin in the area to be treated.
Excessive hooding, with or without redundant skin, in the areas to be treated.
Significant scarring in areas to be treated.
Significant open facial wounds or lesions.
Severe or cystic acne on the face.
Presence of a metal stent or implant in the facial area to be treated.
